Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/publikationen/12569-xaluritamig-a-steap1-cd3-xmab-21-immune-therapy-for-metastatic-castration-resistant-prostate-cancer-results-from-dose-exploration-in-a-first-in-human-study